Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice

British Journal of Cancer

Volumn 82, Issue 2, 2000, Pages 467-471

  Hara, A ^a   Yoshimi, N ^a   Yamada, Y ^a   Matsunaga, K ^a   Kawabata, K ^a   Sugie, S ^a   Mori, H ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Diethylnitrosamine; Fas; Hepatocarcinogenesis; Mouse

Indexed keywords

ANTIBODY; DIETHYLNITROSAMINE; FAS ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG INDUCED CANCER; HAMSTER; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033977986     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0944     Document Type: Article

References (29)

1. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K and Imawari M (1997) Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158: 5283-5291
2. Columbano A, Endoh T, Denda A, Noguchi O, Nakae D, Hasegawa K, Ledda-Columbano GM, Zedda AI and Konishi Y (1996) Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis. Carcinogenesis 17: 395-400
3. Dragani TA, Manenti G and Della Porta G (1986) Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis. Cancer Lett 31: 171-179
4. Dusheiko GM (1990) Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment. Br Med Bull 46: 492-511
5. Frith CH and Ward JM (1979) A morphologic classification of proliferative and neoplaslic hepatic lesions in mice. J Environmen Pathol Toxicol 3: 329-351
6. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
7. Hara A, Yoshimi N, Hirose Y, Ino N, Tanaka T and Mori H (1995a) DNA fragmentation in granular cells of human cerebellum following global ischemia. Brain Res 697: 247-250
8. Hara A, Yoshimi K, Mori H, Iwai T, Sakai N, Yamada H and Niwa M (1995b) Hypothermic prevention of nuclear DNA fragmentation in gerbil hippocampus following transient forebrain ischemia. Neurol Res 17: 461-464
9. Hayashi N and Mita E (1997) Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 12: S223-226
10. Higaki K, Yano H and Kojiro M (1996) Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol 149: 429-437
11. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H and Kamada T (1994) Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19: 1354-1359
12. Jiang Z, Liu Y, Savas L, Smith L, Bonkovsky H, Baker S and Banner B (1997) Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases. Virchows Arch 431: 189-194
13. Klaunig JE, Weghorst CM and Pereira MA (1987) Effect of the age of B6C3F1 mice on phenobarbital promotion of diethylnitrosamine-initiated liver tumors. Toxicol Appl Pharmacol 90: 79-85
14. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH and Moller P (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69: 415-429
15. Lindroos PM, Zarnegar R and Michalopoulos GK (1991) Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 13: 743-750
16. Lipsky MM, Hinton DE, Klaunig JE and Trump BF (1981) Biology of hepatocellular neoplasia in the mouse. III. Electron microscopy of safrole-induced hepatocellular adenomas and hepatocellular carcinomas. J Natl Cancer Inst 67: 393-405
17. Matsuda Y, Amuro Y, Higashino K, Hada T, Yamamoto T, Fujikura M, Yamaguchi K, Shimomura S, Iijima H and Nakano T (1995) Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: possible role of alcohol in promoting carcinogenesis. Hepato-Gastroenterol 42: 151-154
18. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H and Kamada T (1994) Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 204: 468-474
19. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, Fusamoto H and Kamada T (1996) Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 24: 1-7
20. Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C and Levrero M (1995) Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11: 1157-1164
21. Nishimura Y, Hirabayashi Y, Matsuzaki Y, Musette P, Ishii A, Nakauchi H, Inoue T and Yonehara S (1997) In vivo analysis of Fas antigen-mediated apoptosis: effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver. Int Immunol 9: 307-316
22. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T and Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809
23. Okazaki M, Hino K, Fujii K, Kobayashi N and Okita K (1996) Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. Digest Dis Sci 41: 2453-2458
24. Pound AW and McGuire LJ (1978a) Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br J Cancer 37: 585-594
25. Pound AW and McGuire LJ (1978b) Influence of repeated liver regeneration on hepatic carcinogenesis by diethylnitrosamine in mice. Br J Cancer 37: 595-602
26. Rouquet N, Allemand I, Molina T, Bennoun M, Briand P and Joulin V (1995) Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver. Oncogene 11: 1061-1067
27. Saile B, Knittel T, Matthes N, Schott P and Ramadori G (1997) CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol 151: 1265-1272
28. Smith CA, Farrah T and Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulalion, and death. Cell 76: 959-962
29. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA and Nagata S (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274-1279